Drug
Simvastatin Placebo
Simvastatin Placebo is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
2
67%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (33.3%)
Phase 32 (66.7%)
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingearly_phase_1
Topic Simvastatin for Bone Regeneration
NCT07031778
completedphase_3
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
NCT00423488
completedphase_3
The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients
NCT01944176
Clinical Trials (3)
Showing 3 of 3 trials
NCT07031778Early Phase 1
Topic Simvastatin for Bone Regeneration
NCT00423488Phase 3
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
NCT01944176Phase 3
The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3